DocGo Inc.DCGONASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+16598.7%
5Y CAGR+1596.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+16598.7%/yr
Quarterly compound
5Y CAGR
+1596.1%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1403802.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 118145089.57% |
| Q3 2025 | 7.99% |
| Q2 2025 | -18.75% |
| Q1 2025 | -1.25% |
| Q4 2024 | 17.16% |
| Q3 2024 | 32.79% |
| Q2 2024 | -0.83% |
| Q1 2024 | -25.01% |
| Q4 2023 | -1.54% |
| Q3 2023 | 25.67% |
| Q2 2023 | 38.14% |
| Q1 2023 | 8.25% |
| Q4 2022 | 25.37% |
| Q3 2022 | 19.58% |
| Q2 2022 | 0.57% |
| Q1 2022 | -14.74% |
| Q4 2021 | 56.71% |
| Q3 2021 | 28.54% |
| Q2 2021 | 16.78% |
| Q1 2021 | -0.03% |
| Q4 2020 | 84.16% |
| Q3 2020 | 160.22% |
| Q2 2020 | 86.82% |
| Q1 2020 | 0.00% |